Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 40.25
Key Takeaways
Risk factor
High price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers.
Data is available to registered users only
Target Price
The average target price of IMP-A-SDB.ST is 74 and suggests 84% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Data is available to registered users only
Buy
Sell